Canopy Growth (CGC) Cash & Equivalents (2017 - 2026)

Canopy Growth (CGC) reported Cash & Equivalents of $265.9 million for Q1 2026, up 235.27% on a YoY basis from $79.3 million in Q1 2025, and little changed sequentially from $266.3 million in Q4 2025.

Canopy Growth (CGC) Cash & Equivalents (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Cash & Equivalents data on file, last reported at $265.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 235.27% year-over-year to $265.9 million; the trailing twelve-month figure through Mar 2026 stood at $265.9 million (up 235.27% YoY), and the FY2026 full-year result was $265.9 million, up 235.27% from the prior year.
  • Cash & Equivalents steadied at $265.9 million in Q1 2026, from $266.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $612.6 million in Q1 2022 to a low of $79.3 million in Q1 2025.
  • A 5-year average of $270.3 million and a median of $181.2 million in 2023 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents tumbled 76.21% in 2023 and soared 235.27% in 2026, its largest moves.
  • Tracing CGC's Cash & Equivalents over 5 years: stood at $440.6 million in 2022, then plunged by 76.21% to $104.9 million in 2023, then advanced by 10.54% to $115.9 million in 2024, then jumped by 129.74% to $266.3 million in 2025, then dropped by 0.13% to $265.9 million in 2026.
  • Business Quant data shows CGC's Cash & Equivalents at $265.9 million in Q1 2026, $266.3 million in Q4 2025, and $94.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 88.58 Bn 86.72 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.33 Bn 30.39 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.14 Bn 20.99 Bn 648.10 Mn 1.28 Bn
6 RedHill Biopharma 20.53 Bn 20.53 Bn - 3.97 Mn
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.93 Bn 16.62 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn 428.00 Mn
10 Canopy Growth 270.50 Mn 4.57 Mn - 265.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 265.93 Mn
Dec 31, 2025 266.27 Mn
Sep 30, 2025 94.07 Mn
Jun 30, 2025 91.08 Mn
Mar 31, 2025 79.32 Mn
Dec 31, 2024 115.90 Mn
Sep 30, 2024 167.44 Mn
Jun 30, 2024 140.49 Mn
Mar 31, 2024 126.38 Mn
Dec 31, 2023 104.85 Mn
Sep 30, 2023 181.24 Mn
Jun 30, 2023 396.99 Mn
Mar 31, 2023 335.19 Mn
Dec 31, 2022 440.64 Mn
Sep 30, 2022 572.54 Mn
Jun 30, 2022 603.55 Mn
Mar 31, 2022 612.64 Mn
Dec 31, 2021 488.02 Mn
Sep 30, 2021 641.58 Mn
Jun 30, 2021 455.45 Mn